Overview


According to FutureWise analysis the market for Interventional Cardiology Devices in 2023 is US$ 18.89 billion, and is expected to reach US$ 34.75 billion by 2031 at a CAGR of 7.92%.

Interventional Cardiology includes procedures like Angioplasty and Stenting used to treat Cardiovascular Diseases. It includes the use of various devices to perform these procedures. Interventional cardiologists often use catheters as part of their training. These minimally invasive procedures are a viable alternative to open surgery for many patients. The field of interventional cardiology uses a variety of instruments, such as catheters, guidewires, angioplasty balloons, stenting devices, vascular closure devices, atherectomy devices, ultrasounds, and fractional flow reserves. By positioning the catheter at the beginning of a blood vessel, a catheter is able to furnish a blood vessel with the appropriate treatment. Catheters are typically made up of plastic or metal. With the catheter, a cardiologist can view any artery blockage that may exist by allowing dye to flow through it, and then into the arteries. During an Angioplasty, the catheter's tip is mounted with a balloon or some other device. At the narrow section of the artery, a guidewire is used to guide the device or balloon. By using the device mounted on the catheter, the artery is then reopened. Guidewires are long, flexible metal wires that guide various other devices to exactly where the cardiologist wants them to go. A guidewire is threaded along a blood vessel, followed by placing a balloon or a stent over the guidewire at the desired location. In an angioplasty procedure, a balloon-like portion of the catheter is inflated. Through the use of a guidewire, a balloon catheter is positioned at the site of blockage. The balloon is then inflated and deflated simultaneously to push the blockage and restore blood flow in the artery.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Interventional Cardiology Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Interventional Cardiology Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Boston Scientific Corporation
  • Medtronic Plc.
  • Abbott Laboratories
  • Edwards Lifesciences Corporation
  • Terumo Corporation
  • Cordis (A Subsidiary Of Cardinal Health, Inc.)
  • B. Braun Melsungen Ag
  • Koninklijke Philips N.V.
  • ivascular S.l.u.
  • Biosensors International
  • Biotronik SeCo. Kg
  • Penumbra, Inc.
  • Amg International (A Subsidiary Of Q3 Medical)
  • Endocor Gmbh.
  • Insitu Technologies, Inc.
  • Meril Life Sciences Pvt. Ltd.
  • Alvimedica
  • Cardionovum Gmbh
  • SMT
  • Medinol Ltd.
  • Wellinq
  • Scitech
  • Comed B.v. (A Subsidiary Of Lepu Medical Technology Holding)
  • Balton Sp. Z O.o
  • Rontis
  • Stentys Sa

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • Angioplasty Balloons
    • Old/Normal Balloons
    • Drug-eluting Balloons
    • Cutting and Scoring Balloons
  • Angioplasty Stents
    • Drug-eluting Stents
    • Bare-metal Stents
    • Bioabsorbable Stents
  • Structural Heart Devics
    • Aortic Valve Therapy Devices
    • Other Therapy Devices (Mitral valve, pulmonary valve and tricuspid valve and left atrial appendage therapy devices)
  • Catheters
    • Angiography Catheters
    • Guiding Catheters
    • IVUS/OCT Catheters
  • Plaque Modification Devices
    • Atherectomy Devices
    • Thrombectomy Devices
  • Hemodynamic Flow Alteration Devices
    • Embolic Protection Devices
    • Chronic Total Occlusion Devices
  • Other Devices
    • Guidewires
    • Vascular Closure Devices
    • Introducer Sheaths
    • Hemostasis Valves
    • Balloon Inflation Devices

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Interventional Cardiology Devices Market By Product and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Interventional Cardiology Devices Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Interventional Cardiology Devices Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Interventional Cardiology Devices Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Interventional Cardiology Devices Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Angioplasty Balloons
         1.1. Old/Normal Balloons
         1.2. Drug-eluting Balloons
         1.3. Cutting and Scoring Balloons
        2. Angioplasty Stents
         2.1. Drug-eluting Stents
         2.2. Bare-metal Stents
         2.3. Bioabsorbable Stents
        3. Structural Heart Devics
         3.1. Aortic Valve Therapy Devices
         3.2. Other Therapy Devices (Mitral valve, pulmonary valve and tricuspid valve and left atrial appendage therapy devices)
        4. Catheters
         4.1. Angiography Catheters
         4.2. Guiding Catheters
         4.3. IVUS/OCT Catheters
        5. Plaque Modification Devices
         5.1. Atherectomy Devices
         5.2. Thrombectomy Devices
        6. Hemodynamic Flow Alteration Devices
         6.1. Embolic Protection Devices
         6.2. Chronic Total Occlusion Devices
        7. Other Devices
         7.1. Guidewires
         7.2. Vascular Closure Devices
         7.3. Introducer Sheaths
         7.4. Hemostasis Valves
         7.5. Balloon Inflation Devices

  • 8.   North America Interventional Cardiology Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 9.   Latin America Interventional Cardiology Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 10.   Europe Interventional Cardiology Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.7. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 11.   Asia Pacific Interventional Cardiology Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 12.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 13.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 14.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Boston Scientific Corporation
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Medtronic Plc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Abbott Laboratories
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Edwards Lifesciences Corporation
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Terumo Corporation
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Cordis (A Subsidiary Of Cardinal Health, Inc.)
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. B. Braun Melsungen Ag
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Koninklijke Philips N.V.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Ivascular S.l.u.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.Biosensors International
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11.Biotronik SeCo. Kg
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12.Penumbra, Inc.
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13.Amg International (A Subsidiary Of Q3 Medical)
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14.Endocor Gmbh.
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15.Insitu Technologies, Inc.
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16.Meril Life Sciences Pvt. Ltd.
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17.Alvimedica
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18.Cardionovum Gmbh
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
        19.SMT
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview
        20.Medinol Ltd.
         20.1. Company Overview
         20.2. Product Portfolio
         20.3. SWOT Analysis
         20.4. Financial Overview
         20.5. Strategic Overview
        21.Wellinq
         21.1. Company Overview
         21.2. Product Portfolio
         21.3. SWOT Analysis
         21.4. Financial Overview
         21.5. Strategic Overview
        22.Scitech
         22.1. Company Overview
         22.2. Product Portfolio
         22.3. SWOT Analysis
         22.4. Financial Overview
         22.5. Strategic Overview
        23.Comed B.v. (A Subsidiary Of Lepu Medical Technology Holding)
         23.1. Company Overview
         23.2. Product Portfolio
         23.3. SWOT Analysis
         23.4. Financial Overview
         23.5. Strategic Overview
        24.Balton Sp. Z O.o
         24.1. Company Overview
         24.2. Product Portfolio
         24.3. SWOT Analysis
         24.4. Financial Overview
         24.5. Strategic Overview
        25.Rontis
         25.1. Company Overview
         25.2. Product Portfolio
         25.3. SWOT Analysis
            25.4. Financial Overview
         25.5. Strategic Overview
        26.Stentys Sa
         26.1. Company Overview
         26.2. Product Portfolio
         26.3. SWOT Analysis
         26.4. Financial Overview
         26.5. Strategic Overview

  • 15.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 16.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients